What can you say negative? The company has approx $150m cap and $10 billion dollar in products forward looking. And that's what we know about. The strategy beyond what we know is more Billion dollar products.
What is unique is that this is a pharma play obviously. But its a manufacturing play. Tech play. Tough market to enter but a license to print money once you are in. Their overhead is low. Debt is minimal. Assets are significant especially compared to cap. Debt to asset is .20. That's just silly.
We don't worry about the technology working. We don't worry about competition that much really until the numbers get much larger. We need to double our capacity in the near term because of everything happening.
They make stuff They make hard to make stuff others cant just go and make The stuff they make people need and want and is recession proof They can pick and choose what they make and the products are billions of dollars.
Get cash - Develop stuff - launch stuff - get more cash - develop more stuff - launch more stuff - get rich
News 
Market Data 
Discover 
